IDNNA
From Infogalactic: the planetary knowledge core
![]() |
|
Names | |
---|---|
IUPAC name
[2-(4-Iodo-2,5-dimethoxyphenyl)-1-methylethyl]dimethylamine
|
|
Other names
2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine
2,5-Dimethoxy-4-iodo-1-ethyl-(alpha-methyl)amine |
|
Identifiers | |
67707-78-2 ![]() |
|
ChEMBL | ChEMBL11043 ![]() |
ChemSpider | 119009 ![]() |
Jmol 3D model | Interactive image |
PubChem | 135056 |
|
|
|
|
Properties | |
C13H20NO2I | |
Molar mass | 349.211 g/mol |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
IDNNA, or 2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 2.6 mg, and the duration unknown. IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.
See also
External links
<templatestyles src="Asbox/styles.css"></templatestyles>